These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 15542800)

  • 21. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of cystic nephroma and cystic partially differentiated nephroblastoma--a report from the SIOP/GPOH study group.
    Luithle T; Szavay P; Furtwängler R; Graf N; Fuchs J;
    J Urol; 2007 Jan; 177(1):294-6. PubMed ID: 17162067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic nephroma, cystic partially differentiated nephroblastoma and cystic Wilms' tumor in children: a spectrum with therapeutic dilemmas.
    van den Hoek J; de Krijger R; van de Ven K; Lequin M; van den Heuvel-Eibrink MM
    Urol Int; 2009; 82(1):65-70. PubMed ID: 19172100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical implications for liver metastases in nephroblastoma--data from the SIOP/GPOH study.
    Fuchs J; Szavay P; Luithle T; Furtwängler R; Graf N
    Surg Oncol; 2008 Jul; 17(1):33-40. PubMed ID: 17935976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Wilms tumor according to SIOP 9 protocol in Casablanca, Morocco.
    Madani A; Zafad S; Harif M; Yaakoubi M; Zamiati S; Sahraoui S; Benjelloun A; Fehri M; Benchekroun S
    Pediatr Blood Cancer; 2006 Apr; 46(4):472-5. PubMed ID: 16035094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor: past, present and (possibly) future.
    Spreafico F; Bellani FF
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):249-58. PubMed ID: 16445377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Wilms' tumor].
    Graf N
    Praxis (Bern 1994); 1996 Jun; 85(23):753-61. PubMed ID: 8693243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study.
    Nicolin G; Taylor R; Baughan C; Shannon R; Stevens S; Richardson D; Kelsey A; Pritchard-Jones K; Mitchell C
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):175-80. PubMed ID: 17980506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of therapy in Wilms' tumor].
    Kolygin BA; Gaĭdaenko KP; Gafton GI; Punanov IuA
    Vopr Onkol; 1997; 43(4):429-31. PubMed ID: 9381697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical factors in relapses of Wilms' tumor--results for the Polish Pediatric Solid Tumors Study Group.
    Niedzielska E; Bronowicki K; Pietras W; Sawicz-Birkowska K; Trybucka K; Rąpała M; Karpińska-Derda I; Kurylak A; Marciniak-Stępak P; Panasiuk A; Nurzyńska-Flak J; Peregud-Pogorzelski J; Pietrys D; Rurańska I; Sobol G; Stefanowicz J; Szymik-Kantorowicz S; Zubowska M; Godziński J
    Adv Clin Exp Med; 2014; 23(6):925-31. PubMed ID: 25618119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology.
    Castex MP; Rubie H; Stevens MC; Escribano CC; de Gauzy JS; Gomez-Brouchet A; Rey A; Delattre O; Oberlin O
    J Clin Oncol; 2007 Apr; 25(10):1176-82. PubMed ID: 17401006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The advantages of preoperative therapy in Wilms' tumour. A summarised report on clinical trials conducted by the International Society of Paediatric Oncology (SIOP).
    Bürger D; Moorman-Voestermans CG; Mildenberger H; Lemerle J; Voûte PA; Tournade MF; Rodary C; Delemarre JF; Sandstedt B; Sarrazin D
    Z Kinderchir; 1985 Jun; 40(3):170-5. PubMed ID: 2994320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIOP treatment guidelines for renal tumours in small infants: fact or fantasy?
    Levie NS; de Kraker J; Bökkerink JP; Appel IM; Aronson DC
    Eur J Surg Oncol; 2000 Sep; 26(6):567-70. PubMed ID: 11034807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
    Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II: a report from the SIOP 93-01 nephroblastoma trial and study.
    Vujanić GM; Harms D; Bohoslavsky R; Leuschner I; de Kraker J; Sandstedt B
    Pediatr Dev Pathol; 2009; 12(2):111-5. PubMed ID: 18811224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.